China Biologic Produ (CBPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CBPO | HALO | CRSP | ||
Company | China Biologic Produ | Halozyme Therapeutic | Crispr Therapeutics Ag | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 118.01 | 39.56 | 54.48 | ||
High | 120.05 | 39.56 | 55.34 | ||
Low | 117.27 | 38.88 | 53.99 | ||
Last | 119.99 | 39.47 | 54.47 | ||
Change | +1.98 | +0.17 | +0.66 | ||
% Change | +1.68% | +0.43% | +1.23% | ||
Volume | 390,900 | 35,488 | 216,378 | ||
20-Day Average Volume | 113,045 | 826,505 | 1,267,170 | ||
Previous Close | 118.01 | 39.30 | 53.81 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 118.25 | 38.95 | 57.62 | ||
20-Day Raw Stochastic | 97.99% | 37.67% | 13.27% | ||
20-Day Relative Strength | 65.93% | 50.18% | 34.73% | ||
Weighted Alpha | +12.44 | +20.01 | -21.09 | ||
Today's Opinion | 56% Buy | 40% Buy | 40% Sell | ||
Previous Opinion | 8% Sell | 40% Buy | 40% Sell | ||
Last Month's Opinion | 24% Buy | 56% Buy | 24% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +1.45% since 04/13/21 | +1.79% since 04/25/24 | +1.23% since 04/25/24 | ||
Low | 117.27 on 04/20/21 | 37.97 on 04/30/24 | 52.73 on 04/30/24 | ||
High | 120.05 on 04/20/21 | 40.00 on 05/01/24 | 55.97 on 05/01/24 | ||
1-Month | |||||
%Chg | +1.82% since 03/19/21 | -3.17% since 04/02/24 | -16.36% since 04/02/24 | ||
Low | 117.06 on 03/23/21 | 37.73 on 04/19/24 | 52.73 on 04/30/24 | ||
High | 120.05 on 04/20/21 | 41.50 on 04/05/24 | 67.25 on 04/04/24 | ||
3-Month | |||||
%Chg | +1.27% since 01/20/21 | +16.24% since 02/02/24 | -16.00% since 02/02/24 | ||
Low | 115.69 on 01/27/21 | 33.15 on 02/05/24 | 52.73 on 04/30/24 | ||
High | 120.05 on 04/20/21 | 42.64 on 03/13/24 | 91.10 on 02/22/24 | ||
6-Month | |||||
%Chg | +5.61% since 10/20/20 | +14.31% since 11/02/23 | +17.78% since 11/02/23 | ||
Low | 112.29 on 10/26/20 | 33.15 on 02/05/24 | 47.50 on 11/03/23 | ||
High | 120.05 on 04/20/21 | 42.82 on 12/14/23 | 91.10 on 02/22/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 4,722,806 | 4,993,222 | 4,567,555 | ||
Shares Outstanding, K | 39,360 | 127,054 | 84,883 | ||
Annual Sales | 524,370,000 | 829,250,000 | 371,210,000 | ||
Annual Net Income | 152,290,000 | 281,590,000 | -153,610,000 | ||
Last Quarter Sales | 112,100,000 | 230,040,000 | 201,210,000 | ||
Last Quarter Net Income | 23,680,000 | 85,390,000 | 89,350,000 | ||
60-Month Beta | 0.42 | 1.26 | 1.80 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | 0.82 on 02/20/24 | 1.10 on 02/21/24 | ||
Latest Earnings Date | 05/19/21 | 05/07/24 | 05/13/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 29.28 | 14.94 | 0.00 |